Immunology and Breast Cancer

Every disease causes an immune response, which is the first line of defence against the spread of any malignancy. In the case of breast cancer, a connection exists between the immune system and the development of tumours. The environment around the tumour contains a variety of immune cells that may be able to stop the spread of breast cancer. These immune cells may be modulated by therapies used to treat breast cancer. Antigen-specific immunoglobulin is secreted by B lymphocytes, and it may have anticancer characteristics. Breast cancer patients have more B lymphocytes in their bone marrow than healthy individuals do, which can be an important factor in the therapy of breast cancer.

  • Immunogenicity of Breast Cancer
  • Anti-PD-1/PD-L1 Agents in Breast Cancer

Related Conference of Immunology and Breast Cancer

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Immunology and Breast Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in